P
TECH icon

&Partners’s Bio-Techne TECH Stock Holding History

&Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Sell
12,729
-701
-5% -$37.9K ﹤0.01% 1509
2026
Q1 		$701K Sell
13,430
-1,903
-12% -$114K ﹤0.01% 1501
2025
Q4 		$902K Buy
+15,333
New +$932K ﹤0.01% 1280

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

&Partners's TECH Position: Q2 2026 in Review

&Partners reduced its Bio-Techne (TECH) stake by 5.2% in Q2 2026, selling an estimated $37.9K and leaving 12,729 shares worth $852K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

&Partners first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. The position peaked at $902K in Q4 2025. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • &Partners held 12,729 shares of Bio-Techne worth $852K as of Q2 2026.
  • &Partners sold 701 Bio-Techne shares in Q2 2026, an estimated $37.9K.
  • Bio-Techne made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1509 holding.
  • &Partners first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • &Partners's Bio-Techne position peaked at $902K in Q4 2025.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.